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To develop a more realistic assessment of costs, herein named “true” costs, the extra-cancer from medical radiation,
environmental damage from imaging paraphernalia and radioactive wastes must be included as long-term costs
from imaging examinations. It is urgent to define the “true” costs across imaging modalities as it interferes on
physicians’ decision to request an exam and on research projects such as cost-effectiveness analysis. Cardiology is
the specialty that most will benefit from the outcome as cardiovascular exams represent almost 30% of the total
exams acquired annually worldwide.From exam total costs to environmental costs and
extra-costs from cancer
While innovations in medical imaging represent an ex-
ceptional success story, the escalating average costs of
imaging is representing a major health economic and so-
cietal burden. The cost of diagnostic imaging in the
United States (U.S.) is estimated in $100 billion per year
[1] and it is steadily increasing. The average total im-
aging cost per patient per year in the U.S. almost dou-
bled between 1997 and 2006, from $229 to $443 [2].
Several factors contributed to this rapid increase such as
high tech modalities, defensive medicine, self-referral,
patient demand and overutilization of tests [3].
The estimation of costs across imaging modalities is a
crucial information, as it has impact not only in the clin-
ical setting, i.e. physicians’ decision to request an exam;
but also research results, i.e. cost-effectiveness analysis.
Often, physicians lean toward the imaging modality with
the lowest cost for any given comparable accuracy [4].
As only for Europe, if we set the average cost (not
charges) of an ultrasound without stress as equal to 1
(cost comparator), the cost of a cardiac computed tom-
ography (CT) is 3.1 ×; single photon emission computed
tomography (SPECT) is 3.2 ×; cardiovascular magnetic
resonance imaging (MRI) is 5.5 ×; and positron emission* Correspondence: picano@ifc.cnr.it
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reproduction in any medium, provided the ortomography (PET) scan is 14.0 × [4]. In addition, the
cost range of a certain imaging exam is wide, even be-
tween states from the same country. For instance, angi-
ography cost can vary from $1,000 to $4,000;
meanwhile, PET exam can cost between $1,100 and
$2,700. In our standpoint, so far, we have only imperfect
cost evaluation, partial proof of benefit, and incomplete
documentation of risk-benefit, typically considered as
proven simply by ignoring downstream societal and en-
vironmental costs [3,5].
Final or total cost to produce an exam equals the sum
of direct and indirect costs. Each institution has its own
formula to allocate direct and indirect costs; so total cost
variations between institutions is expected. In general, at
the imaging department, the direct costs account for the
higher percentage of total costs. Direct costs of produ-
cing an exam include, but are not limited to, labor, ma-
terial, film, equipment; while indirect costs include
transportation, internet, heating, sewer, lighting, etc.
Herein, we suggest that three factors must be included
in the total costs of producing an examination in order
to correspond to what we denominate as “true” cost: en-
vironmental costs, extra-costs from (fatal and non-fatal)
cancer caused by medical radiation, and radionuclide
wasting costs. In addition, special attention must be
given to the running costs (i.e. electricity) of each im-
aging modality as it affects greatly the environment.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 illustrates a hypothetical pathway of the “true”
costs of imaging including environmental, extra-cancer
and radioactive waste costs. Environmental and extra-
cancer costs have impact on indirect costs; meanwhile,
radioactive wastes affect both direct and indirect costs,
the latter through the environment. As far as the electri-
city goes, the cost is usually allocated under “institu-
tional cost” having impact only in the direct cost.
Herein, we suggest that electricity cost should also be
accounted as indirect cost because of its impact in the
environment.
Assessment of environmental costs: still an
elusive goal
The long-term costs of environment damage caused by
imaging methods paraphernalia have been neglected. In
the sustainability era where people are adapting their
habits to a more “green” life with the expectation to pre-
serve the ecosystem for future generations, it is more
than fair that health care practitioners begin to consider
the environment topic in their daily practice. Undoubt-
edly, the environment cost per imaging methods para-
phernalia should be taken into account as part of theFigure 1 Illustrates a hypothetical pathway of the “true” costs of ima
radioactive waste costs (service). Environmental and extra-cancer costs h
and indirect costs, the latter through the environment.“true” costs as its impact not only the ecosystem but also
the human health.
The magnitude of the environmental impact, in an
economic viewpoint, of certain products and materials
during life time can be calculated through life cycle as-
sessment (LCA). Damage to mineral and fossil resources
(millijoule surplus energy), damage to ecosystem quality
(% plant species * Kilometers squared * year) and damage
to human health [disability adjusted life years (DALY)] are
the three final categories affected by several factors
such as heavy metals, nuclides, hydrochlorofluorocarbon
(HCFC), carbon dioxide (CO2), polycyclic aromatic hydro-
carbons (PAH), fossil fuels, and land transformation. The
same software used to calculate LCA also carry on life
cycle costing (LCC) analysis. LCC is a tool that provides a
cost estimation of the environmental damage costs and it
is expressed through indirect costs.
The environmental cost has impact solely in the indir-
ect costs; however, some of the resources and materials
included in the LCA and LCC analyses also affect direct
costs (Figure 1). Translating to the imaging setting, for
instance, radionuclides and gadolinium are the main
components of contrast agents but also materials affect-
ing LCA and LCC results. Contrast is accounted as dir-
ect costs; meanwhile, LCC result impacts indirect costs.ging including environmental, extra-cancer (human) and
ave impact on indirect costs; and radioactive wastes affect both direct
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LCA to demonstrate the environmental impact of car-
diac imaging tests for the diagnosis of coronary artery
disease. The study showed that echocardiography is the
imaging method that least causes human health harm,
ecosystem damage and uses less resources; i.e. the effect
of an ultrasound examination on human health was in
the order of 1/10 to 1/100th of SPECT and cardiovascu-
lar MRI, with 1/5 to 1/50th of the ecosystem effects and
1/20 to 1/100th of their resource utilization. Aside of
addressing the environmental damage, the authors
briefly recognized the need of evaluating the environ-
mental costs of medical imaging [6].
The inclusion of environmental costs in imaging cost
assessment is a conceptual breakthrough: still, some lim-
itations and appropriateness of the employed approach
should be considered as a platform for future improve-
ment and refinements of the model.
Electricity, extra-cancer from ionizing test and
radionuclides wastes
The LCA results, and thus LCC, are greatly affected by
energy consumption. According to COCIR -on the
self-regulatory initiative echo-design of energy using
products for medical imaging equipment on December
2011- the energy consumption from imaging methods
corresponds up to 80% of environmental impact on LCA
[7]. In other words, environmental damage from imaging
paraphernalia has positive correlation with scanner size
(thus electricity consumption).
Electricity has impact in both direct and indirect costs;
the latter through environment (Figure 1). The direct
cost of electricity can be calculated by the following for-
mula: kW/hours * electricity price. The electricity price
ranges widely depending upon location (country, states
and cities). The environment cost, thus indirect costs,
can be calculated through LCC, using the CO2 emission
as the material (or variable). CO2 emission per day
(Kilograms) is equal to consumption of electricity
(Kilowatts) times use time (hours) × CO2 emission coef-
ficient (KgCO2/kWh).
The U.S. is the leading country in CO2 emission per
capita/year: 20 tons of CO2. The CO2 emission average
worldwide is 3.1 tons, and in Italy is 8.1 tons. The cost
of 1 ton of CO2 emission is $50. Ultrasound is the
modality that emits lowest CO2 per exam (approxi-
mately 2.2 Kg in Italy and 2.9 Kg in USA) whereas, 3.0 T
MRI emits the highest (229 Kg in Italy and 302 Kg in
USA). The cost of CO2 per exam should be also account
in the “true” costs.
In the last 10 years, the medical imaging community
has become increasingly aware of the need to include
long-term cancer risk caused by ionizing radiation in the
risk-benefit assessment of ionizing testing [8-10]. This iscertainly important for the individual patient and for the
society perspective, since small individual risks multiplied
by billions examinations become a significant population
risks, and up to 10% of all cancers can be due to medical
radiation exposure [11,12]. However, this is also a cost and
probably a significant one. It has been calculated that only
in the U.S., 29,000 new ca
ncers will arise from computed tomography performed in
one year [13], and 7,000 new cancers from myocardial per-
fusion imaging [14].
The costs and savings of technological upgrading in
terms of cancer prevention have been addressed by the
food drug administration (FDA) some years ago. The
group estimated that 723 lives per year spared radiation
induced cancer mortality 30 years after the start of imple-
mentation of amendments. The average annual financial
savings of $519 in the first 10 years of implementation
greatly exceeds estimated average annual cost of $49
million to manufactures and to the FDA [15].
Aside electricity and extra-cancer, the cost of radio-
active waste also should be accounted in the “true” costs.
The costs of radioactive waste have been increasing
steadily and it is estimate that in the past 30 years the
cost had increased approximately 1000 times: $36/m3 in
1980, $14,286/m3 in 2005 and $35,714/m3 in 2010 [16].
The radioactive waste is accounted as both direct and
indirect costs, the latter through the environment.Future perspective: addressing the 4 dimension of
imaging costs
The assessment of economic, environmental, societal and
biologic costs of medical imaging (and its paraphernalia) is
becoming increasingly important topic [17,18]. This is
especially relevant for cardiologists since cardiovascular
imaging represents 29% of the several billion imaging ex-
aminations performed annually worldwide [19]. A better,
more responsible use of common resources by cardiolo-
gists is destined to become one of the new features, and
not the least important, of a good practice of medicine.Competing interests
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